Power Life Sciences Inc.
Clinical study participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine. People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
Migraine
Migraine Disorders
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Official Title : | An In Depth Study Examining Patterns in the Clinical Trial Experiences of Migraine Patients |
| Actual Study Start Date : | January 2025 |
| Estimated Primary Completion Date : | January 2026 |
| Estimated Study Completion Date : | January 2027 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 65 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.